Selank is a synthetic peptide anxiolytic developed from the human immunoglobulin G (IgG) protein. It was created by the Institute of Molecular Genetics in Russia and is used clinically there for anxiety-related conditions. It is not FDA-approved in the United States.
What Selank Does (Mechanism of Action)
Selank’s primary actions include:
-
Modulation of GABA
- Increases the expression and activity of GABA, the brain’s main calming neurotransmitter.
- Results in reduced anxiety and a more stable mood.
-
Regulates Serotonin and Dopamine
- Helps balance key neurotransmitters involved in:
- Mood
- Motivation
- Stress response
-
Improves BDNF Levels
- May increase brain-derived neurotrophic factor, which supports:
- Memory
- Learning
- Cognitive function
-
Stabilizes the Enkephalin System
- Provides anti-anxiety effects without sedation or dependence.
Potential Benefits ( Research-Based Only )
Research and clinical use suggest Selank may support:
- Reduced anxiety
- Stress resilience
- Improved mood stability
- Enhanced mental clarity & focus
- Better memory and learning
- Reduced fatigue
- Immune system modulation (via Tuftsin sequence)
Selank is known for being non-sedating and non-habit-forming, unlike benzodiazepines.
